Enhancing Precision of the Single-antigen Bead (SAB) Assay: Considerations and Challenges
Our capacity to recognize and manage allosensitized transplant
recipients and optimize organ allocation has been
greatly improved by the development of single-antigen bead
tests for detecting human leukocyte antigen antibodies. The
main drawbacks of this technology have been thoroughly
discussed in the literature, covering problems like artifacts
that result in nonspecific background, variability, lack of uniformity,
and difficulties in data interpretation. Consequently,
it is not always easy to understand single-antigen bead data.
This review will discuss the interpretation of donor-specific
antibody data while considering the associated technical limitations.
To ensure the correct clinical application of this test
and to enhance the quality of antibody data used to support
published clinical research in the era of epitope-based computational
matching algorithms, a detailed understanding of
the single-antigen bead assay is necessary.
recipients and optimize organ allocation has been
greatly improved by the development of single-antigen bead
tests for detecting human leukocyte antigen antibodies. The
main drawbacks of this technology have been thoroughly
discussed in the literature, covering problems like artifacts
that result in nonspecific background, variability, lack of uniformity,
and difficulties in data interpretation. Consequently,
it is not always easy to understand single-antigen bead data.
This review will discuss the interpretation of donor-specific
antibody data while considering the associated technical limitations.
To ensure the correct clinical application of this test
and to enhance the quality of antibody data used to support
published clinical research in the era of epitope-based computational
matching algorithms, a detailed understanding of
the single-antigen bead assay is necessary.